Literature DB >> 20339859

Tubal ligation via colpotomy or laparoscopy: a retrospective comparative study.

Wei-Hsi Chang1, Jah-Yao Liu, Yu-Chi Yeh, Gwo-Jang Wu, Yung-Jong Chiang, Mu-Hsien Yu, Chi-Huang Chen.   

Abstract

OBJECTIVE: To compare transvaginal with laparoscopic tubal sterilization with respect to invasiveness and outcomes.
METHOD: The outcomes of 103 patients who received interval tubal sterilization were compared. Group A (n = 38) underwent the transvaginal approach, group B (n = 38) a laparoscopic approach, and group C (n = 27) underwent mini-laparotomy due to difficulties encountered in one of the other procedures.
RESULTS: There were no significant differences in patient age between the groups. There was no significant difference in operative time or blood loss between groups A and B. Operative time was significantly longer in group C (120 ± 35 min) than group A (40 ± 5 min) or group B (45 ± 9 min) (p < 0.05). Blood loss was significantly greater in group C (120 ± 30 ml) than in group A (10 ± 2 ml) or group B (10 ± 1 ml) (p < 0.05). The cost of transvaginal tubal sterilization was the lowest, and that of mini-laparotomy was the highest. There was no contraception failure in any group.
CONCLUSIONS: Transvaginal tubal sterilization is technically more difficult, but when correctly performed it is not associated with an increased complication rate, and is less costly than laparoscopic sterilization.

Entities:  

Mesh:

Year:  2010        PMID: 20339859     DOI: 10.1007/s00404-010-1435-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Invited commentary: reproductive organ surgeries and breast cancer risk--apples, oranges, or fruit cocktail?

Authors:  David J Press; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-02-14       Impact factor: 4.897

2.  Safety of culdotomy as a surgical approach: implications for natural orifice transluminal endoscopic surgery.

Authors:  Mary Catherine Tolcher; Eleftheria Kalogera; Matthew R Hopkins; Amy L Weaver; Juliane Bingener; Sean C Dowdy
Journal:  JSLS       Date:  2012 Jul-Sep       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.